LUNDBECK NA LTD has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), United States and Brazil. Its main competitors in its focus markets pharmaceuticals are SYNOSENS KUTATO ES FEJLESZTOE, SCOTT DONALD E and BEBAAS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Hong Kong | 1 | |
#7 | India | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Roberts Michael J | 9 |
#2 | Rowse Gerry | 7 |
#3 | Szakacs Cameron | 7 |
#4 | Cioffi Christopher | 7 |
#5 | Schwieterman William | 7 |
#6 | Hewitt Arthur L | 4 |
#7 | Hewitt L Arthur | 3 |
#8 | Pedder Simon | 2 |
#9 | Arthur L Hewitt | 1 |
#10 | Peroutka Stephen | 1 |
Publication | Filing date | Title |
---|---|---|
US2013243875A1 | Threo-DOPS controlled release formulation | |
KR20140131335A | Improving postural stability administering droxidopa | |
EP2709608A1 | Compositions for treating postural reflex abnormality caused by parkinson's disease | |
EP2363124A1 | Pharmaceutical compositions comprising droxidopa |